Literature DB >> 17101223

Peripheral p70S6k levels and emotional memory in patients with Alzheimer's disease.

Marc Paccalin1, Fuad Al Khidir, Stéphanie Pain Barc, Claudette Pluchon, Marie-Christine Perrault-Pochat, Roger Gil, Jacques Hugon.   

Abstract

Alzheimer's disease (AD) is clinically marked at the onset, by memory disturbances affecting explicit memory. Emotional explicit memory is enhanced in normal subjects and remained less affected at the beginning of AD. The kinase p70S6k participates in the control of protein translation and seems also implicated in the process of synaptic plasticity and the formation of memory at the molecular level. In a previous study, we have shown that peripheral p70S6k level is correlated with the decline of cognitive and memory functions in patients with AD. The goal of the present study was to analyse emotional and neutral explicit memory in AD patients and to evaluate the levels of active p70S6k in lymphocytes by western blots. The results reveal that the difference between emotional and neutral memories are correlated with the levels of peripheral p70S6k in patients with AD, as well as with the global cognitive scores assessed by the Mini Mental Status Examination. The decline of emotional memory in AD patients is reflected by the decrease of p70S6k levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101223     DOI: 10.1016/j.neulet.2006.07.053

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients.

Authors:  Milena Damjanac; Guylène Page; Stéphanie Ragot; Guillaume Laborie; Roger Gil; Jacques Hugon; Marc Paccalin
Journal:  J Cell Mol Med       Date:  2009-02-04       Impact factor: 5.295

Review 2.  mTOR-dependent signalling in Alzheimer's disease.

Authors:  Jin-Jing Pei; Jacques Hugon
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

Review 3.  PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease.

Authors:  Milena Morel; Julien Couturier; Claire Lafay-Chebassier; Marc Paccalin; Guylène Page
Journal:  J Cell Mol Med       Date:  2009-07-07       Impact factor: 5.310

Review 4.  Activation of mTOR: a culprit of Alzheimer's disease?

Authors:  Zhiyou Cai; Guanghui Chen; Wenbo He; Ming Xiao; Liang-Jun Yan
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-09       Impact factor: 2.570

Review 5.  Blood-Based Kinase Assessments in Alzheimer's Disease.

Authors:  Jacques Hugon; François Mouton-Liger; Emmanuel Cognat; Julien Dumurgier; Claire Paquet
Journal:  Front Aging Neurosci       Date:  2018-11-14       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.